3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
4
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pneumonia
1
Pleuropulmonary blastoma
1
Pancreatitis, Chronic
1
Neurocognitive Disorders
1
Neuroblastoma
1
Neoplasm Metastasis
1
Meningioma
1
Lung Diseases, Interstitial
1
Immunoglobulin G4-Related Disease
1
Ganglioneuroblastoma
1
Carcinoma, Renal Cell
1
Carcinoma, Adenoid Cystic
1
Carcinoma
1
Breast Carcinoma In Situ
1
Autoimmune Pancreatitis
1
Anus Neoplasms
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Oxaliplatin
10
Leucovorin
9
Fluorouracil
9
Specimen Handling
6
Cetuximab
6
Bevacizumab
6
Magnetic Resonance Spectroscopy
4
pembrolizumab
3
cemiplimab
3
Pemetrexed
3
fludarabine
2
dehydroftorafur
2
aldesleukin
2
Surveys and Questionnaires
2
Nivolumab
2
Irinotecan
2
Immunoglobulin G
2
Gemcitabine
2
Folfox protocol
2
Disulfides
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
Biopsy
2
ulixertinib
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
tipiracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Observation
×
30 days
×
Clear all
No trials found.